Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice
about
Coadjuvants in the Diabetic Complications: Nutraceuticals and Drugs with Pleiotropic EffectsPhosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and CognitionThe role of phosphodiesterase-5 inhibitors in prostatic inflammation: a reviewThe Effect of Sorafenib, Tadalafil and Macitentan Treatments on Thyroxin-Induced Hemodynamic Changes and Cardiac AbnormalitiesA critical view on cardiovascular risk in systemic sclerosis.Computational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics.Chronic inhibition of phosphodiesterase 5 with tadalafil attenuates mitochondrial dysfunction in type 2 diabetic hearts: potential role of NO/SIRT1/PGC-1α signaling.From rapalogs to anti-aging formula.Cardiac NO signalling in the metabolic syndrome.Chronic Inhibition of PDE5 Limits Pro-Inflammatory Monocyte-Macrophage Polarization in Streptozotocin-Induced Diabetic MicePDE5 inhibitors as therapeutics for heart disease, diabetes and cancerTadalafil Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice.Pathological ventricular remodeling: mechanisms: part 1 of 2Molecular mechanisms of diabetic cardiomyopathy.Pharmacodynamics, pharmacokinetics and clinical efficacy of phosphodiesterase-5 inhibitors.Influence of the PDE5 inhibitor tadalafil on redox status and antioxidant defense system in C2C12 skeletal muscle cells.Double-stranded RNA-dependent protein kinase signalling and paradigms of cardiometabolic syndrome.Targeting phosphodiesterase 5 as a therapeutic option against myocardial ischaemia/reperfusion injury and for treating heart failure.Pathophysiological Fundamentals of Diabetic Cardiomyopathy.IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus.Hydrogen sulfide mediates the cardioprotective effects of gene therapy with PKG-Iα.PDE5 Inhibitor Tadalafil and Hydroxychloroquine Cotreatment Provides Synergistic Protection against Type 2 Diabetes and Myocardial Infarction in Mice.Tadalafil prevents acute heart failure with reduced ejection fraction in mice.Tadalafil, a long acting phosphodiesterase inhibitor, promotes bone marrow stem cell survival and their homing into ischemic myocardium for cardiac repair.Udenafil, a Phosphodiesterase 5 Inhibitor, Reduces Body Weight in High-Fat-Fed Mice.Nickel(II)-assisted enantiomeric differentiation and quantitation of tadalafil by direct electrospray ionization mass spectrometry.Effect of tadalafil administration on insulin secretion and insulin sensitivity in obese men.Acute effects of physical exercise and phosphodiesterase's type 5 inhibition on serum 11β-hydroxysteroid dehydrogenases related glucocorticoids metabolites: a pilot study.
P2860
Q26741423-9824747F-E28B-476D-BBDD-8F2708F92607Q26771954-BF92BB5B-4DE6-4E5C-83ED-1AB7FA5A5FD7Q26785428-BB023256-6E0C-4BB9-9CAB-1F968753E841Q28551385-77ED6EE5-E653-44CE-9B24-34CFB15249ACQ30249024-66056410-7A51-4B1F-89C2-1B3C914BF5DAQ30278668-ADBEE152-0D8C-4919-9D9F-4FCC0218A5AFQ33701938-D243C297-03DF-4871-A173-92E685E2C4BFQ33829205-F0BD0F79-33C1-4C72-9DA1-5E173525C6A8Q35204828-F7029506-FF0F-4CE0-9971-7391DCD29D8CQ35593122-CB902343-449F-43B6-A531-867DF206EF82Q35827798-7805542D-5D46-4275-AF3B-8A2CC4F600C9Q36082944-BBFB5B21-8863-4FD6-B5EB-40E02B8198BFQ37241166-8DA6DEE2-8CB0-4781-8353-00474838913BQ37672583-E4E99D65-0215-4092-AD9F-F2BB7ADB8677Q38815890-16E2A5A1-3820-4835-AE8A-B0A7768B8430Q38913850-A7DC1F4D-F64A-4398-A0DC-2DB481172115Q39043385-D5D16E6D-72AE-4CA4-82B3-DFF79BF6056AQ39141728-F9FA00ED-809F-40DE-83D0-93CEDB86220AQ39195672-118938CD-54C1-4806-BB5A-6D20B62EFF75Q39403443-9430C155-D7FE-4454-9CB3-91A4A586A4A0Q41189484-867A4086-1A23-4C19-AD23-5EB72C070F4BQ41913523-7B1DD46B-9C0A-494F-94B1-540420DFB957Q45004611-416E907D-27D7-48CD-A9C3-88361AF1011FQ45354313-2E6B0F67-8129-442C-BFA8-1214FA279D65Q47175833-5B781816-AE18-4F37-B8A9-B4C5BD69FEDBQ48062290-5E8E7A43-BE5E-4FD3-BA9D-1A4846BA2A9BQ53473350-A8D59B14-6609-4A79-A204-40BBAEA14994Q54188009-0BAD7CCD-48B4-40D6-A523-40C4B5B271B4
P2860
Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice
@ast
Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice
@en
Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice
@nl
type
label
Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice
@ast
Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice
@en
Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice
@nl
prefLabel
Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice
@ast
Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice
@en
Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice
@nl
P2093
P2860
P1433
P1476
Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice
@en
P2093
Amit Varma
David E Durrant
Fadi N Salloum
Nicholas N Hoke
Rakesh C Kukreja
P2860
P304
P356
10.1371/JOURNAL.PONE.0045243
P407
P50
P577
2012-09-21T00:00:00Z